Cargando…
Blood utilisation and transfusion reactions in adult patients transfused with conventional or pathogen‐reduced platelets
Pathogen‐reduced (PR) platelets are routinely used in many countries. Some studies reported changes in platelet and red blood cell (RBC) transfusion requirements in patients who received PR platelets when compared to conventional (CONV) platelets. Over a 28‐month period we retrospectively analysed p...
Autores principales: | Bahar, Burak, Schulz, Wade L., Gokhale, Amit, Spencer, Bryan R., Gehrie, Eric A., Snyder, Edward L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7003815/ https://www.ncbi.nlm.nih.gov/pubmed/31566724 http://dx.doi.org/10.1111/bjh.16187 |
Ejemplares similares
-
Comparative risk of pulmonary adverse events with transfusion of pathogen reduced and conventional platelet components
por: Snyder, Edward L., et al.
Publicado: (2022) -
Transfusion of pathogen‐reduced platelet components without leukoreduction
por: Sim, Joycelyn, et al.
Publicado: (2019) -
Amustaline‐glutathione pathogen‐reduced red blood cell concentrates for transfusion‐dependent thalassaemia
por: Aydinok, Yesim, et al.
Publicado: (2019) -
Aged versus fresh autologous platelet transfusion in a two‐hit healthy volunteer model of transfusion‐related acute lung injury
por: van Baarle, Floor L. F., et al.
Publicado: (2022) -
Expected individual benefit of prophylactic platelet transfusions in hemato‐oncology patients based on bleeding risks
por: Cornelissen, Loes L., et al.
Publicado: (2021)